60
Participants
Start Date
April 10, 2025
Primary Completion Date
March 1, 2026
Study Completion Date
December 30, 2026
transcutaneous electrical nerve stimulation (TENS)
"A TENS 3000-unit, which is FDA and health Canada approved (Licence No.: 95655) and operated by a small 9V block battery will be used. Potential participants will receive a detailed written explanation of the TES protocol and a brief demonstration of how it works, including the feeling produced by the skin stimulator. Patient-specific TES thresholds will be determined after informed written consent for study participation is obtained. Surface electrode pads will be placed on the ventral surface of the forearm, and 1-Hz pulses will be gradually administered with an increase in current. Patients will be asked to report when they first feel the stimulation and when it becomes annoying. The milliamp current associated with these two levels of stimulation will be recorded on the participant's baseline data collection form. The annoying thresholds for all study participants will be used to deliver stimuli in response to respiratory depression in the PACU."
ACTIVE_NOT_RECRUITING
Toronto General Hospital, Toronto
RECRUITING
Toronto General Hospital, Toronto
University Health Network, Toronto
OTHER
University of Toronto
OTHER